Our findings have shown that liraglutide and exenatide can improve glucose metabolism, reduce weight gain, and improve lipid profiles in patients with schizophrenia who are at risk for developing metabolic disorders
We recently reported studies examining a novel glycolipid surfactant-peptide conjugation technology designed to prolong in vivo terminal elimination half-life (T 1/2 ) and demonstrated its tunable impact on pharmacokinetic (PK) parameters for analogs of both parathyroid hormone 19 and GLP-1R/GCGR dual agonists 20
Pediatrics 151(2):e2022060640 Singhal V, Sella AC, Malhotra S (2021) Pharmacotherapy in pediatric obesity: current evidence and landscape
Ethics declarations Competing interests Through M.H.H.K., the VU University Medical Center has received research grants from AstraZeneca, Boehringer Ingelheim, Novo Nordisk and Sanofi
From advanced supplements and wearable nutrition to clean skincare and fresh-prepared meals, Le-Vels THRIVE product line is designed to help individuals reach their highest potentialinside and out
That third factor is the one you can control